Arlington Trust’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$23.2K Buy
246
+10
+4% +$954 ﹤0.01% 401
2026
Q2
$20K Hold
236
– – ﹤0.01% 385
2026
Q1
$16.7K Buy
+236
New +$17.7K ﹤0.01% 356
2025
Q4
– Sell
-2,210
Closed -$182K – 561
2025
Q3
$182K Hold
2,210
– – 0.03% 188
2025
Q2
$178K Sell
2,210
-160
-7% -$12.3K 0.03% 187
2025
Q1
$190K Hold
2,370
– – 0.04% 178
2024
Q4
$194K Hold
2,370
– – 0.04% 178
2024
Q3
$195K Sell
2,370
-160
-6% -$12K 0.04% 170
2024
Q2
$178K Hold
2,530
– – 0.04% 162
2024
Q1
$187K Buy
2,530
+42
+2% +$2.93K 0.05% 137
2023
Q4
$165K Buy
2,488
+947
+61% +$59.3K 0.05% 150
2023
Q3
$96.9K Buy
+1,541
New +$96K 0.04% 114

Other funds holding MET

Arlington Trust's MET Position: Q3 2026 in Review

Arlington Trust increased its MetLife (MET) stake by 4.2% in Q3 2026, buying an estimated $954 and bringing the position to 246 shares worth $23.2K. The position accounts for ﹤0.01% of the portfolio, ranked #401.

Arlington Trust first reported a position in MET in Q3 2023 and has held it in 12 quarters since. The position peaked at $195K in Q3 2024. 623 funds tracked by Wall St. Rank hold MET as of Q3 2026.

  • Arlington Trust held 246 shares of MetLife worth $23.2K as of Q3 2026.
  • Arlington Trust bought 10 MetLife shares in Q3 2026, an estimated $954.
  • MetLife made up ﹤0.01% of Arlington Trust's portfolio in Q3 2026, its #401 holding.
  • Arlington Trust first reported a position in MetLife in Q3 2023 and has held it in 12 quarters since.
  • Arlington Trust's MetLife position peaked at $195K in Q3 2024.
  • 623 funds tracked by Wall St. Rank held MetLife as of Q3 2026.

Based on Arlington Trust's 13F filing for Q3 2026, filed 20 Oct 2026.